“Within the next several months, the court will be closing the Risperdal, Essure and Elmiron mass tort programs, as the lawyers and self-represented parties work through the remaining cases on the docket,” Judge Joshua Roberts, head of the Philadelphia Court of Common Pleas Complex Litigation Center, said.